[Not Available].
作者信息
Welkoborsky H-J, Dietz A, Deitmer T
机构信息
Klinik für HNO-Heilkunde, Kopf-Halschirurgie, Klinikum Nordstadt, Hannover.
Univ. HNO-Klinik, Leipzig.
出版信息
Laryngorhinootologie. 2020 Jun;99(6):370-373. doi: 10.1055/a-1168-0855. Epub 2020 May 8.
Abstract
摘要
相似文献
1
[Not Available].
Laryngorhinootologie. 2020 Jun;99(6):370-373. doi: 10.1055/a-1168-0855. Epub 2020 May 8.
2
Otolaryngology residency strategies during the COVID-19 pandemic.新冠疫情期间的耳鼻喉科住院医师培训策略
Clin Teach. 2020 Oct;17(5):544-546. doi: 10.1111/tct.13236. Epub 2020 Jul 28.
3
Leveraging COVID-19-Inspired Changes to Advance Otolaryngology-Here to Stay.利用受新冠疫情启发而产生的变化推动耳鼻喉科学发展——持续存在
JAMA Otolaryngol Head Neck Surg. 2020 Jul 1;146(7):605-607. doi: 10.1001/jamaoto.2020.1188.
4
Otolaryngology Residency Application during the SARS-CoV-2 (COVID-19) Pandemic.SARS-CoV-2（COVID-19）大流行期间的耳鼻喉科学住院医师申请。
Otolaryngol Head Neck Surg. 2020 Jul;163(1):89-90. doi: 10.1177/0194599820925037. Epub 2020 May 5.
5
To Be a Partner in Life-Resident Training During the COVID-19 Pandemic.在新冠疫情期间成为生活中的伙伴——住院医师培训
JAMA Otolaryngol Head Neck Surg. 2020 Jul 1;146(7):601-602. doi: 10.1001/jamaoto.2020.0921.
6
Otologic and Audiologic Considerations for COVID-19.COVID-19 的耳科学和听力学考虑因素。
Otolaryngol Head Neck Surg. 2020 Jul;163(1):110-111. doi: 10.1177/0194599820928989. Epub 2020 May 12.
7
[Suggestions for emergency operation of otorhinolaryngology head and neck during the period of prevention and control of 2019 novel coronavirus].[2019新型冠状病毒防控期间耳鼻咽喉头颈外科急诊手术建议]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Apr 7;55(4):322-325. doi: 10.3760/cma.j.cn115330-20200204-00238.
8
Telemedicine During the COVID-19 Pandemic: A Pediatric Otolaryngology Perspective.新冠疫情期间的远程医疗：小儿耳鼻喉科视角。
Otolaryngol Head Neck Surg. 2020 Sep;163(3):480-481. doi: 10.1177/0194599820931827. Epub 2020 May 26.
9
Proactive measures for the pandemic COVID-19 infection in outpatient clinics of Otolaryngology Department.耳鼻喉科门诊应对新型冠状病毒肺炎感染的主动措施
Kaohsiung J Med Sci. 2020 Jun;36(6):473-474. doi: 10.1002/kjm2.12235. Epub 2020 Jun 3.
10
Coronavirus disease 2019 in otolaryngology: special issue.2019年冠状病毒病在耳鼻咽喉科领域：特刊
J Laryngol Otol. 2020 Aug;134(8):659-660. doi: 10.1017/S0022215120001942.
本文引用的文献
1
COVID-19 and hearing difficulties.新型冠状病毒肺炎与听力障碍
Am J Otolaryngol. 2020 Jul-Aug;41(4):102496. doi: 10.1016/j.amjoto.2020.102496. Epub 2020 Apr 19.
2
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
3
Audiological profile of asymptomatic Covid-19 PCR-positive cases.无症状新冠病毒 PCR 阳性病例的听力学特征。
Am J Otolaryngol. 2020 May-Jun;41(3):102483. doi: 10.1016/j.amjoto.2020.102483. Epub 2020 Apr 10.
4
Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review.新冠病毒感染患者的心脏受累：风险因素、预测指标及并发症：综述
J Card Surg. 2020 Jun;35(6):1302-1305. doi: 10.1111/jocs.14538. Epub 2020 Apr 19.
5
COVID-19 in otolaryngologist practice: a review of current knowledge.耳鼻喉科医生实践中的 COVID-19：当前知识综述。
Eur Arch Otorhinolaryngol. 2020 Jul;277(7):1885-1897. doi: 10.1007/s00405-020-05968-y. Epub 2020 Apr 18.
6
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.新型冠状病毒肺炎患者的抗体检测及动态特征。
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934. doi: 10.1093/cid/ciaa461.
7
Epidemiology and clinical features of COVID-19: A review of current literature.新型冠状病毒肺炎的流行病学和临床特征：文献复习。
J Clin Virol. 2020 Jun;127:104357. doi: 10.1016/j.jcv.2020.104357. Epub 2020 Apr 10.
8
Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington.华盛顿金县 SARS-CoV-2 感染医护人员发病时的症状筛查。
JAMA. 2020 May 26;323(20):2087-2089. doi: 10.1001/jama.2020.6637.
9
Central nervous system manifestations of COVID-19: A systematic review.COVID-19 相关的中枢神经系统表现：一项系统性综述。
J Neurol Sci. 2020 Jun 15;413:116832. doi: 10.1016/j.jns.2020.116832. Epub 2020 Apr 11.
10
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.SARS-CoV-2：洛匹那韦/利托那韦、达芦那韦/乌苯美司、羟氯喹、瑞德西韦、法匹拉韦等药物治疗新型冠状病毒的抗病毒治疗的最新报告。
Curr Med Chem. 2020;27(27):4536-4541. doi: 10.2174/0929867327666200416131117.
Zotero 插件